Search
for
Sort by
Research 271–300 of 1000+
- Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- A review of Janus kinase inhibitor use in scarring alopecia
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Koilonychia in a Patient with Alopecia Areata.
- Alopecia Areata: Clinical Treatment
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Activity‐based therapeutic algorithm for folliculitis decalvans: A practical tool for effective management
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Role of janus kinase inhibitors in the treatment of alopecia areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Treating Alopecia Areata: Current Practices Versus New Directions
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata